CLINICAL AND VIROLOGIC RESPONSES TO A RECOMBINANT VACCINIA HIV-1 GP160 VACCINE (HIVAC-1E)

被引：0
|
作者：
COREY, L
COLLIER, A
COOMBS, R
ARDITTI, D
HU, SL
GREENBERG, P
MCLAREN, C
MARTIN, R
DRAGAVON, J
CHALOUPKA, K
机构：
[1] UNIV WASHINGTON,SEATTLE,WA 98195
[2] BRISTOL MYERS CORP,WALLINGFORD,CT
来源：
CLINICAL RESEARCH | 1989年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A562 / A562
页数：1
相关论文
共 50 条
  • [31] ENVELOPE-SPECIFIC ANTIBODIES IN THE SALIVA OF INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-1 GP160
    VASUDEVACHARI, MB
    UFFELMAN, KW
    KOVACS, J
    YEH, CK
    LANE, HC
    SALZMAN, NP
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1992, 5 (08): : 817 - 821
  • [32] Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn)
    Guerra, E
    Ricci, G
    Carlesimo, M
    Varani, AR
    Pontesilli, O
    Scala, E
    Mezzaroma, I
    Pierdominici, M
    Pandolfi, F
    Antinori, A
    DeLuca, A
    Murri, R
    Ammassari, A
    Ortona, L
    Aiuti, F
    DEVELOPMENT AND APPLICATIONS OF VACCINES AND GENE THERAPY IN AIDS, 1996, 48 : 147 - 154
  • [33] SAFETY AND IMMUNOGENICITY OF LAMBDA-BACULOVIRUS DERIVED HIV-1 IIIB RECOMBINANT GP160 VACCINE (VAXSYN(R)) IN HUMANS
    KEEFER, M
    BELSHE, R
    CLEMENTS, M
    GRAHAM, B
    COREY, L
    BOLOGNESI, D
    STABLEIN, D
    FAST, P
    MONTEFIORI, D
    SMITH, G
    DOLIN, R
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 : S113 - S113
  • [34] Heparin enhances the furin cleavage of HIV-1 gp160 peptides
    Pasquato, A.
    Dettin, M.
    Basak, A.
    Gambaretto, R.
    Tonin, L.
    Seidah, N. G.
    Di Bello, C.
    FEBS LETTERS, 2007, 581 (30) : 5807 - 5813
  • [35] FURIN IS IMPORTANT BUT NOT ESSENTIAL FOR THE PROTEOLYTIC MATURATION OF GP160 OF HIV-1
    GU, ML
    RAPPAPORT, J
    LEPPLA, SH
    FEBS LETTERS, 1995, 365 (01) : 95 - 97
  • [36] Megalomicin inhibits HIV-1 replication and interferes with gp160 processing
    José, ES
    Muñoz-Fernández, MA
    Alarcón, B
    VIROLOGY, 1997, 239 (02) : 303 - 314
  • [37] PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160
    BERMAN, PW
    GREGORY, TJ
    RIDDLE, L
    NAKAMURA, GR
    CHAMPE, MA
    PORTER, JP
    WURM, FM
    HERSHBERG, RD
    COBB, EK
    EICHBERG, JW
    NATURE, 1990, 345 (6276) : 622 - 625
  • [38] CROSS-NEUTRALIZING ANTIBODIES IN RABBITS IMMUNIZED WITH HIV-1 GP160 PURIFIED FROM SIMIAN CELLS INFECTED WITH A RECOMBINANT VACCINIA VIRUS
    KLANIECKI, J
    DYKERS, T
    TRAVIS, B
    SCHMITT, R
    WAIN, M
    WATSON, A
    SRIDHAR, P
    MCCLURE, J
    MOREIN, B
    ULRICH, JT
    HU, SL
    LEWIS, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (10) : 791 - 798
  • [39] IMMUNIZATION OF CHIMPANZEES WITH BACULOVIRUS-EXPRESSED HIV-1(IIIB) GP160
    NIGIDA, SM
    BESS, JW
    PYLE, SW
    MOREIN, B
    PUTNEY, SD
    ARTHUR, LO
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 150 - 151
  • [40] RECOMBINANT GP160 VACCINATION SCHEDULE AND MHC HLA TYPE AS FACTORS INFLUENCING CELLULAR-RESPONSES TO HIV-1 ENVELOPE GLYCOPROTEIN
    GORSE, GJ
    PATEL, GB
    NEWMAN, FK
    MANDAVA, M
    BELSHE, RB
    VACCINE, 1995, 13 (13) : 1170 - 1179
12345